Recent procurements of medicinal products for the cardiovascular system in Ireland
2023-06-13Fibrinogen concentrate used for congenital afibrinogenaemia and dysfibrinogenaemia (Irish Blood Transfusion Service)
Human fibrinogen concentrate is used for congenital afibrinogenaemia and dysfibrinogenaemia states for treatment of bleeding complications. It is also used in acquired hypofibrinogenemia conditions such as massive haemorrhage, acquired coagulopathy, liver disease with bleeding and in obstetric haemorrhage. The product should be licensed for these clinical indications and approved by the HPRA. Fibrinogen, in presence of thrombin, activates FVIII and calcium, which is necessary to convert fibrinogen into โฆ
View the procurement ยป